Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03829033 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.

Study acronym: ARTSCAN V
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor 3 versions Re-verified since Feb 27, 2020, no change to tracked fieldsv2-v4
  2. Minor Study First Submitted
In this trial, patients with early squamous cell carcinoma of the tonsil with clinical stage T1-2 (p16-positive or p16-negative) N0-1 (p16-positive)/N0-N2b (p16-negative) according to American Joint Committee on Cancer (AJCC) 8th edition, aimed for unimodal and ipsilateral treatment with radiotherapy with curative intent will be included. The patients will be randomized to in a 1:1 ratio to receive radiotherapy with either photons (conventional radiotherapy) versus radiotherapy with protons.
Trial Details
NCT Number NCT03829033
Lead Sponsor Lund University Hospital
Conditions
(from sponsor)
Tonsil Cancer
Related terms Tonsillar Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov